雅虎香港 搜尋

搜尋結果

  1. 其他人也問了

  2. Clinical Care of C. auris infections. Prevention of Invasive Infections. Surveillance of C. auris. The emerging fungus, C. auris can cause severe multidrug-resistant illness in hospitalized patients.

  3. 2023年6月1日 · Most cases can be treated with a class of antifungal drugs called echinocandins. However, some C. auris infections are resistant to all three main classes of antifungal medication. High dose of multiple antifungals may be required for treatment. Skin lesions such as boils or abscesses may require incision and drainage. Prevention.

    • Overview
    • Transmission methods for Candida auris
    • Signs and symptoms of Candida auris infection
    • Treatment options for Candida auris infections
    • Is treatment for Candida auris covered under insurance or Medicare?
    • How long does it take to recover from a Candida auris infection?
    • Should I be worried about Candida auris?
    • Takeaway

    Candida auris (C. auris) is a fungus that can cause infection and illness in humans. It was first identified in Japan in 2009, although the earliest infection is believed to have occurred in South Korea in 1996.

    Since its identification, unrelated strains of the fungus have been found in multiple countries worldwide, including the United States.

    The fungus is a type of yeast that can enter the bloodstream and spread throughout the body. Treatment is often complex because most people who become seriously ill with C. auris already have an acute or chronic condition.

    Additionally, the fungus doesn’t always respond to standard antifungal medications. High doses of multiple antifungal medications are sometimes needed to clear an infection.

    C. auris is typically transmitted in hospitals and other healthcare settings. The fungus can spread via contaminated surfaces, such as medical equipment and furniture. It can also be transmitted from person to person.

    The fungus has been found in many regions throughout the world, including:

    •North America

    •South America

    •East Asia

    •South Asia

    The symptoms of C. auris infection can vary widely depending on the person and on the part of the body affected.

    The most common symptoms include a fever and chills, but these symptoms are common in many other infections. Additionally, most people with C. auris are already being treated for another condition. This can make symptoms difficult to identify.

    Antifungal medications treat C. auris infections. Generally, doctors prescribe a class of medications called echinocandins.

    However, some C. auris infections are resistant to all forms of antifungal medication, including echinocandins. When this occurs, doctors prescribe high doses of multiple antifungal medications.

    The primary treatment for C. auris is a class of antifungal medication called echinocandins. Your insurance coverage for this medication might depend on the specific echinocandin a doctor prescribes and whether it’s a generic or brand-name prescription.

    Prices without insurance start at an average of about $50 per treatment injection. You might need several injections to treat an infection.

    The amount of time it takes to recover from C. auris infection depends on the severity of the infection and the response to treatment.

    Some cases of C. auris are difficult to treat and can last several rounds of antifungal medication. Others are mild and respond well to treatment.

    However, it’s important to note that even when you no longer have symptoms, you will still carry the fungus. This is called “being colonized with C. auris.”

    Although the fungus will no longer make you sick, it will be possible to transmit it to others. This is why the CDC recommends indefinite isolation and infection precautions in healthcare settings for people with C. auris.

    C. auris is a serious infection. It can be fatal if it enters the bloodstream.

    Healthy people rarely develop C. auris infections. Most fatal cases develop in people who are hospitalized and already have a life threatening condition.

    Additionally, although the CDC is watching for new outbreaks of C. auris, infections are relatively rare. According to the most recent data, nearly all U.S. states have fewer than 100 cases of C. auris.

    You can take standard infection precautions to help reduce the risk of a C. auris infection. This includes frequent handwashing and not sharing towels, washcloths, utensils, toiletries, or other items that come in close contact with your body. It’s also a good idea to always keep any wounds clean and covered.

    Candida auris is a fungal infection that can cause serious illness. The infection primarily affects people who are already being treated for a serious health condition in a hospital or long-term care setting.

    Infections can be difficult to treat and might be resistant to antifungal medications. Treatment with multiple antifungal medications is often required. Indefinite isolation is often required following an infection.

  4. 2022年10月21日 · Candida auris is an emerging, multidrug resistant fungal pathogen that causes considerable morbidity and mortality. First identified in Japan in 2009, it has since been reported in more than 40 countries. C. auris can persist for long periods on different environmental surfaces as well as the skin.

    • 10.20411/pai.v7i2.535
    • 2022
    • Pathog Immun. 2022; 7(2): 46-65.
  5. This JAMA Insights Clinical Update discusses the diagnosis, treatment, prognosis, and infection-prevention measures for Candida auris.

  6. 2024年4月24日 · Key points. Echinocandins are the initial recommended treatment for adults and children over 2 months. Amphotericin B deoxycholate at 1 mg/kg daily is the initial recommended treatment for infants under 2 months. Reports of echinocandin-resistant and pan-resistant cases are increasing.

  7. 2024年4月24日 · Candida auris (C. auris) is a type of yeast that is often resistant to antifungal treatments. C. auris can cause invasive infections and can also colonize patients without causing infection. Only clinical infections should be treated.